Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded the inspection with ...

For any FDA-approved facility, it is mandatory to conform to the US regulator's cGMP or current Good Manufacturing Practice ...

Cipla, India's third-biggest drugmaker by sales, reported a fourth-quarter profit that beat estimates on Tuesday, helped by ...

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has classified the current Good ...

Cipla, India's No. 3 drugmaker by sales, reported a fourth-quarter profit that beat estimates on Tuesday, helped by strong ...

US Department of Health and Human Services expects drugmakers to align US prices for brand-name products across markets ...

Cipla has launched an innovative combination of 3 HIV/AIDS drugs, Viraday that needs to be taken just once a day for effective treatment. Cipla has launched an innovative combination of 3 HIV/AIDS ...

Cipla, which also makes anti-allergic drug Cetirizine, said revenue from its drugs business in India rose 3.5%, while revenue from its North American market surged 39%. Cipla's profit growth had ...

"Going forward all our growth engines will be fueled by our digital transformation initiatives," Cipla Managing Director and Global ... innovative drug-device combinations and even bio-drugs that are ...

NEW DELHI: Indian Pharmaceutical company Cipla has offered to manufacture an ... particular drug than the individual effect of both the drugs combined. India To Procure 1 Million Doses Of Tamiflu ...

Cipla Ltd is preparing to launch drugs for diabetes and obesity in India, other emerging markets, and the US, as it sees a huge opportunity for these formulations, a top official of the ...